Aspreva Pharmaceuticals has named Dr. J. William Freytag as chairman and CEO, succeeding Richard Glickman.
Alvine Pharmaceuticals has appointed Abhay Joshi, Ph.D. as president and CEO.
The Los Alamos National Laboratory spin-out CIVA has named John R. Grizz Deal its president and CEO.
Circassia technology has named former GSK chairman Sir Richard Sykes as its new chairman of the board.
Isolagen announced that the company's CFO, Declan Daly, has been appointed to the position of COO.
Encysive Pharmaceuticals announced that Gordon H. Busenbark has resigned as CFO effective July 13, 2007. The company expects to announce its plans regarding the CFO position over the next several weeks.
StemCyte has appointed Robert Dickey IV as senior vice president and CFO.
NPS Pharmaceuticals has promoted Francois Nader, M.D., to executive vice president and COO.
Synovics Pharmaceuticals announced that Steven Getraer has been appointed executive vice president and CFO.
Egalet has appointed Bertrand Damour as its CFO and executive vice president.
Novavax has named Len Stigliano vice president, CFO and treasurer.
MicroIslet announced that Jonathan R. T. Lakey, Ph.D., M.S.M., was named the company's chief scientific officer.
InNexus Biotechnology has named Dr. Thomas Kindt as chief scientific officer.
Sysmex America announced that Andreas Braun, M.D., Ph.D., has been named scientific affairs director for the company's life sciences division.
Gerrit van den Dool will assume expanded duties in the newly created position of vice president sales for Sigma-Aldrich and Dr. David A. Smoller, 44, will become the new president of the company's Research Biotech business unit.
Medivation has appointed Sarvajit Chakravarty, Ph.D., as vice president of medicinal chemistry.
Cylene Pharmaceuticals has hired Dr. David M. Ryckman as vice president of manufacturing and pharmaceutical operations. Ryckman will lead Cylene's scale-up and manufacturing operations.
Thierry Darcis, MD, MBA, has joined ViroPharma as vice president, general manager, ViroPharma Europe. Richard Bax, MBBS, FRCP, MRCGP, FFMP joins ViroPharma as vice president, clinical development and medical affairs, ViroPharma Europe.
Auriga Laboratories has appointed Rick Coulon to the position of vice president of consumer brands.
ForteBio has named Katherine J. Flagg as vice president of sales.
Sean Alan Reade joins Pharm-Olam as vice president of global regulatory affairs.
Orexigen Therapeutics has named Heather Turner, J.D. as vice president and general counsel.
EnWave Corporation has named Dr. Roger W. Graham to the company's Scientific Advisory Board.
ImClone Systems has appointed Thomas F. Deuel as a director.
Dr. Burton Malkiel has joined Theravance's board of directors.